Cubist Pharma

Years after Cubist buyout, Merck scores a new Zerbaxa indication. Can it jump-start sales?
Fierce Pharma
Mon, 06/3/19 - 07:45 pm
Merck
Cubist Pharma
Zerbaxa
FDA
hospital-acquired infections
Layoffs at Cubist come amid a steady flow of senior execs out of Merck
Bizjournals.com
Sun, 03/8/15 - 10:10 am
Merck
Cubist Pharma
layoffs
Merck dumps 120 Cubist researchers after its $9.5B merger
Fierce Biotech
Thu, 03/5/15 - 05:51 pm
Merck
Cubist Pharma
layoffs
R&D
The long, strange story of Cubist's Cards Against Biotechnology
Fierce Pharma Marketing
Wed, 03/4/15 - 12:28 pm
Cubist Pharma
Pharma's top 10 M&A deals of 2014
Fierce Pharma
Thu, 02/19/15 - 07:51 am
M&A
Actavis
Allergan
Forest Labs
GSK
Novartis
Bayer
Merck
Cubist Pharma
Roche
InterMune
Mylan Labs
Abbott Labs
Questcor
Mallinckrodt
Eli Lilly
Sun Pharma
Ranbaxy
Cubist: Zerbaxa Upholds The Potential To Replace Cubicin
Seeking Alpha
Mon, 01/5/15 - 04:06 pm
Cubist Pharma
antibiotics
Zerbaxa
Cubicin
Merck
Merck looks for $8B bridge loan for Cubist acquisition
Reuters
Mon, 12/15/14 - 09:24 pm
Merck
M&A
Cubist Pharma
Merck’s $8.4 Billion Deal for Cubist Looks $2 Billion Too Expensive Now
WSJ Online
Wed, 12/10/14 - 08:13 am
Merck
Cubist Pharma
M&A
Cubicin
antibiotics
Cubist sales force seen as potential boon for Merck intestinal drug
Yahoo/Reuters
Tue, 12/9/14 - 10:13 pm
Cubist Pharma
M&A
Merck
drug reps
Will Tetraphase Pharmaceuticals Be The Next Antibiotic-Maker To Be Acquired After Cubist Pharmaceuticals
Bidness Etc.
Tue, 12/9/14 - 11:40 am
Tetraphase Pharmaceuticals
Cubist Pharma
Merck
M&A
After Big Cubist Buy, Are These 2 Stocks Next to Be Acquired?
24/7 Wall St
Tue, 12/9/14 - 09:56 am
Cubist Pharma
M&A
Cempra
Achaogen
Merck says still plans Cubist purchase, despite patent setback
Yahoo/Reuters
Tue, 12/9/14 - 09:22 am
Merck
Cubist Pharma
patents
Cubicin
M&A
Cubist Barred From Blocking Generic Cubicin Beyond 2016
Bloomberg
Tue, 12/9/14 - 08:06 am
Cubist Pharma
Merck
Cubicin
antibiotics
Merck Triggers The Race to Replace Cubist
Forbes
Mon, 12/8/14 - 03:49 pm
Merck
Cubist Pharma
M&A
antibiotics
antibiotic resistance
Merck buying Cubist Pharmaceuticals for $8.4 billion, will help address antibiotic resistance
Yahoo/AP
Mon, 12/8/14 - 08:07 am
Merck
Cubist Pharma
M&A
Merck in talks to acquire Cubist for over $8 billion: Sources
CNBC
Sat, 12/6/14 - 12:37 am
Merck
Cubist Pharma
M&A
It Could be a Big December for Biotech ETFs
Yahoo/ETF Trends
Thu, 12/4/14 - 08:31 am
biotech
ETFs
Incyte
Puma Biotechnology
Cubist Pharma
5 Critical Biotech Drug Dates and Events for December
24/7 Wall St
Mon, 12/1/14 - 04:45 pm
biotech
Incyte
ruxolitinib
Cubist Pharma
ceftolozane/tazobactam
Biocryst
peramivir
Vertex Pharmaceuticals
Kalydeco
Pozen
PA8140/PA32540
Cubist Pharmaceuticals names chief executive
Pharmafile
Wed, 10/29/14 - 03:51 pm
Cubist Pharma
Shire may turn acquirer after AbbVie deal collapse
Seeking Alpha
Sun, 10/19/14 - 12:33 pm
Shire
M&A
Cubist Pharma
NPS Pharmaceuticals

Pages